872 related articles for article (PubMed ID: 17171686)
21. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
22. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
23. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
[TBL] [Abstract][Full Text] [Related]
24. [Determination of DNA content in salivary gland tumors].
Yáñez M; Roa I; Villaseca M; Fuentealba P
Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
[TBL] [Abstract][Full Text] [Related]
25. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
26. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
[TBL] [Abstract][Full Text] [Related]
27. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
28. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.
Declercq J; Van Dyck F; Braem CV; Van Valckenborgh IC; Voz M; Wassef M; Schoonjans L; Van Damme B; Fiette L; Van de Ven WJ
Cancer Res; 2005 Jun; 65(11):4544-53. PubMed ID: 15930271
[TBL] [Abstract][Full Text] [Related]
29. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
30. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
31. [Expression of p16 and nm23 genes in salivary gland tumors].
Gong L; Chen ZL; Hu J; Huo HY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):155-7. PubMed ID: 15190803
[TBL] [Abstract][Full Text] [Related]
32. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.
Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z
Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035
[TBL] [Abstract][Full Text] [Related]
33. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
34. Translocation-associated salivary gland tumors: a review and update.
Weinreb I
Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
[TBL] [Abstract][Full Text] [Related]
35. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
[TBL] [Abstract][Full Text] [Related]
36. Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases.
Katabi N; Sukhadia P; DiNapoli SE; Weinreb I; Hahn E; Ghossein R; Xu B
Histopathology; 2024 Jan; 84(2):387-398. PubMed ID: 37849332
[TBL] [Abstract][Full Text] [Related]
37. [Phenotype-genotype correlations in salivary gland tumors. Status of molecular analysis].
Röser K; Löning T
Laryngorhinootologie; 2001 Nov; 80(11):639-41. PubMed ID: 11702271
[No Abstract] [Full Text] [Related]
38. Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.
Vékony H; Röser K; Löning T; Ylstra B; Meijer GA; van Wieringen WN; van de Wiel MA; Carvalho B; Kok K; Leemans CR; van der Waal I; Bloemena E
Genes Chromosomes Cancer; 2009 Feb; 48(2):202-12. PubMed ID: 19009612
[TBL] [Abstract][Full Text] [Related]
39. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations.
Kas K; Voz ML; Röijer E; Aström AK; Meyen E; Stenman G; Van de Ven WJ
Nat Genet; 1997 Feb; 15(2):170-4. PubMed ID: 9020842
[TBL] [Abstract][Full Text] [Related]
40. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
